A Comparison of Motivations for Marijuana Use in HIV-Positive and HIV-Negative Adults
While medicinal marijuana use is common among persons with HIV, it is not known whether persons with HIV are more motivated to use marijuana medically compared to HIV-negative counterparts. This study examined motivations for marijuana use in a sample of 94 HIV+ and HIV− adults. Participants used marijuana 21.27 days in the last 30 days on average. HIV+ participants reported using marijuana for medical reasons more often than HIV− participants, but HIV+ and HIV− participants did not differ in other domains. Problematic marijuana use was associated with motives, regardless of HIV status. Motives were associated with mental and physical health functioning, but there were no interactions between motivations and HIV status. Overall this study found that motivations were similar for HIV+ and HIV− participants. Future research including qualitative work to further understand motivations would benefit the field, as would research examining the effectiveness of marijuana in treating physical symptoms.
KeywordsMarijuana Cannabis Marijuana use motives HIV/AIDS Marijuana use disorders
We thank all the men and women who participated in this study.
This study was funded by grants K23-DA028660, R03-DA035670, and T32-AI007392 from the United States National Institutes of Health. The NIH had no further role in study design, data collection, analysis and interpretation of data, writing the report, or in the decision to submit the paper for publication.
Compliance with Ethical Standards
Conflict of interest
All authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 1.Center for Behavioral Health Statistics and Quality. Key substance use and mental health indicators in the United States: results from the 2015 National Survey on Drug Use and Health. Rockville: Substance Abuse and Mental Health Services Administration; 2016.Google Scholar
- 2.APA. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.Google Scholar
- 4.Mimiaga MJ, Reisner SL, Grasso C, et al. Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS research network of integrated clinical systems cohort. Am J Public Health. 2013;103(8):1457–67.CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Lutge EE, Gray A, Siegfried N. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS. Cochrane Database Syst Rev. 2013;2013:005175.Google Scholar
- 15.National Conference of State Legislatures. State Medical Marijuana Laws. 2018. http://www.ncsl.org/research/health/state-medical-marijuana-laws. Accessed 10 Feb 2018.
- 20.First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders, research version, patient/non-patient edition. New York: Biometrics Research, New York State Psychiatric Institute; 1996.Google Scholar
- 22.Sobell LC, Sobell MB. Timeline follow-back user’s guide: a calendar method for assessing alcohol and drug use. Toronto: Addiction Research Foundation; 1996.Google Scholar
- 32.Ware JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User’s manual for the SF-36v2 health survey. 2nd ed. Lincoln: QualityMetric Incorporated; 2007.Google Scholar
- 36.Ware JE, Kosinski M, Dewey JE. How to score version 2 of the SF-36 health survey (Standard and Acute Forms). 2nd ed. Lincoln: QualityMetric, Inc.; 2000.Google Scholar
- 37.Sheehan DV, Lecrubier Y, Sheehan KH, et al. The mini international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatr. 1998;59(Suppl 30):22–33.Google Scholar